Skip to main content

Sprague John M's Form 4 filing

T2 Biosystems, Inc. (TTOO) · filed Mar 9, 2023

Accession no.
0000899243-23-007726
Filed
Mar 9, 2023
Trade date
Feb 20-28, 2023
Filing delay
17 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.68K. It was filed 17 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sprague John MCIK 0001730056Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 20, 2023Common StockMOption exerciseAcquired+4,000–F1–7,047Direct
Feb 22, 2023Common StockSSaleDisposed−1,545$0.65−$1,004.255,502Direct
Feb 24, 2023Common StockMOption exerciseAcquired+2,914–F1–8,416Direct
Feb 28, 2023Common StockSSaleDisposed−1,148$0.59−$677.327,268Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 20, 2023Common StockMOption exerciseDisposed−4,000$0.00$08,000Direct
Feb 24, 2023Common StockMOption exerciseDisposed−2,914$0.00$02,914Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)